Fluicell AB (publ) (STO:FLUI)

Sweden flag Sweden · Delayed Price · Currency is SEK
10.80
-0.40 (-3.57%)
At close: Mar 6, 2026
-28.90%
Market Cap 14.84M
Revenue (ttm) 15.22M
Net Income (ttm) -8.33M
Shares Out 1.37M
EPS (ttm) -6.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,081
Average Volume 9,435
Open 11.00
Previous Close 11.20
Day's Range 10.10 - 11.30
52-Week Range 7.45 - 30.00
Beta 1.41
RSI 50.60
Earnings Date Feb 20, 2026

About Fluicell AB

Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clam... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 11
Stock Exchange Nasdaq Stockholm
Ticker Symbol FLUI
Full Company Profile

Financial Performance

In 2025, Fluicell AB's revenue was 15.22 million, an increase of 184.54% compared to the previous year's 5.35 million. Losses were -8.33 million, -46.28% less than in 2024.

Financial Statements

News

There is no news available yet.